All Kinds of News for June 07, 2017
Outcomes research is an integral part of the Skyland Trail evidence-based treatment model. Skyland Trail employs evaluative instruments considered to be gold standards in the mental health field to measure the effectiveness of the organization's mental health treatment programs.
Clients complete standardized clinical assessments during the admissions process and again at discharge. The assessments measure clients' symptoms, hope for their futures, attitudes about medication and treatment, and the impact of mental illness on their ability to function and complete activities of daily living.
Outcome data from 2008 through 2016 consistently confirm that the unique, integrated, whole person approach offered by Skyland Trail helps clients experience reduced symptoms, increased hope, more positive attitudes about medication adherence and improved skills for completing daily activities and functioning in their communities.
Key overall client outcome measures include:
- 90 percent of all clients experienced a statistically significant improvement in functionality, symptoms and social relationships (1)
- 83 percent of clients completed treatment with a positive attitude about taking psychiatric medication (3)
- 80 percent of all clients experienced a statistically significant improvement in hope (2)
Skyland Trail also conducts assessments specific to each diagnosis treated. These disease-specific measures ensure that evidence-based treatment is working effectively across all diagnoses. Clients are assessed every two weeks throughout treatment, based on the confirmed diagnosis at admission. The summary of 2016 client outcomes data highlighted exceptional results for patients with depression.
Clinical outcomes suggest that for depressed patients who graduate from Skyland Trail’s program, 90 percent have statistical and clinical response to treatment and a full 40 percent reach remission from depression. Clinical research studies in depression suggest that valid treatments typically result in at least 40 percent response and lower remission rates. These outcomes indicate that Skyland Trail’s evidence-based treatment strategies yield exceptional outcomes for patients with depression compared to other standard treatments.
Key outcome measures for clients with depression include:
- 90 percent of patients with depression experienced statistically significant improvement (5)
- 40 percent of patients with depression who admitted with MADRS score >20 graduated with a MADRS score <85 (This is considered remission.) (5)
- 40 percent reduction in depression symptoms was the median response of those who did not reach remission scores (5)
- 62 percent average improvement in feelings of hope among patients with depression (2)
- 53 percent average improvement in attitude toward activities of daily living and overall functioning among patients with depression (1)
- 81 percent of patients with mania experienced statistically significant reduction of their manic symptoms (6)
- 84 percent of patients with anxiety experienced statistically significant improvement in control of anxiety (7)
- 85 percent of patients with thought disorders experienced statistically significant improvement in symptoms of psychosis (4)
The full 2016 Outcomes Research Summary is available online.
About Skyland Trail Located in Atlanta, Skyland Trail is a nationally recognized nonprofit mental health treatment organization serving adults ages 18 and older with a primary psychiatric diagnosis. Through our residential and day treatment programs, we help our clients grow, recover and reclaim their lives. We’re focused on individuals with complex mental health issues, helping them understand that they can be – and are – more than a diagnosis. We offer expert, evidence-based psychiatric care alongside a compassionate, holistic path to wellness. Our integrated mental, medical, and social model helps clients develop strategies to improve mental health, physical wellness, independence, and relationships with family and friends. Unique therapies offered include music, art and horticultural therapy; workforce and school readiness; primary care services; family therapy; and healthy living and nutrition coaching.
- Results are significant at the p<.05 significance level. The 32-item Behavior and Symptom Identification Scale (BASIS-32): © Copyright McLean University, Affiliate of Harvard Medical School.
- Results are statistically significant at the p<.05 significance level. Beck Hopelessness Scale: Beck AT, Weissman A, Lester D, Trexler L. (1074). The measurement of pessimism: The Hopelessness Scale. Journal of Consulting and Clinical Psychology, 42(6), 861-865.
- Results are statistically significant at the P<.05 significance level. Medication Attitude Inventory: Hogan TP, Awad AG, & Eastwood R. (1983). A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychological Medicine, 13, 177-183.
- Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports. 1962; 10:799-812.
- Montgomery, S.A. & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
- Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133:429-435, 1978.
- Hamilton M: The assessment of anxiety states by rating. British Journal of Medical Psychology, 32:50-55,1959.